Navigation Links
Global Biosimulation Market 2014-2018 a New Research Report added to ReportsnReports.com
Date:12/8/2013

Dallas, Texas (PRWEB) December 08, 2013

The Global Biosimulation market is witnessing increasing collaborations and partnerships between vendors. Such collaborations are aiding innovation in the market. For instance, Genedata is collaborating with Insilico Biotechnology AG, which is a Germany-based provider of software and solutions for the simulation of living cells, to support life science companies in improving and enhancing their biotechnological production methods. Additionally, a number of vendors in the Global Biosimulation market (http://www.reportsnreports.com/reports/271328-global-biosimulation-market-2014-2018.html) collaborate with pharmaceutical companies. For instance, in May 2013, Accelrys Inc., a US-based provider of scientific enterprise software, signed a three-year agreement with Pfizer Inc., a pharmaceutical company, for the use of its products such as, modeling and simulation software, by Pfizer's researchers worldwide.

Analysts forecast the Global Biosimulation market to grow at a CAGR of 18.31 percent over the period 2013-2018. According to the report, one of the most important drivers is the reduction in the drug discovery and development costs of pharmaceutical companies as a result of deploying biosimulation software solutions during the R&D process. Since such software brings about an understanding of clinical outcomes before human trials, their use adds immense value to pharmaceutical companies involved in the R&D of drugs, and helps companies reduce costs.

Further, the report states that one of the major challenges in the market is the high R&D costs associated with the development of biosimulation software. Several biosimulation models offer a virtual patient population to aid the development and testing of drugs, but thes
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. NIH awards $20 million over 5 years to train next generation of global health researchers
2. Canada should play a role in addressing the global cancer epidemic
3. Global cardiology leaders meet in Dubai
4. Global, common approach to pharmaceutical supply chain integrity the focus of workshop
5. International breast health global summit will focus on supportive care and quality of life
6. Scientists rewrite rulebook on breast cancer in landmark global study
7. Global CVD leaders call the world to action - 25 by 2025 - from the World Congress of Cardiology
8. Centre for Global Non-Communicable Diseases launched to tackle killer diseases
9. UCLA researchers combat global disease with a cell phone, Google Maps and a lot of ingenuity
10. New study identifies how information technology is used to solve global health challenges
11. New global report says US lags behind 130 other nations in preterm birth rate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/26/2014)... DW-InductionHeating.com (DaWei Induction Heating Co.) is a comprehensive high-tech ... marketing of a series of induction heating equipment. Today, ... of induction brazing equipments . , According to ... refers to the joining of two or more ... manager says that there are fundamental differences in the ...
(Date:12/25/2014)... This is a professional and in-depth study ... with a focus on the Chinese market. The report ... Sterilizers manufacturers and is a valuable source of guidance ... industry. This report provides a basic overview of the ... this part, the report presents the company profile, product ...
(Date:12/25/2014)... TX (PRWEB) December 26, 2014 The ... to 2023” focuses on the current treatment landscape, unmet ... cancer market. TS-1 is an anti-cancer drug which is ... orally and is also used for treating gastric cancer ... and otastat potassium. The drug was first approved in ...
(Date:12/25/2014)... the popular online supplier of wedding dresses and special occasion ... black one-shoulder cocktail dresses . In addition, all these elegant ... prices, up to 70% off. , The development ... You know, we have thousands of frequent callers in the ... can visit our website for more details. The current special ...
(Date:12/25/2014)... Recently, BellasDress has launched ... wedding dresses. BellasDress has chosen their best-selling lace wedding ... for the holiday season. , Now, BellasDress.com features ... gowns here at discount prices. The business hopes everyone ... website. , “All our elegant products are ...
Breaking Medicine News(10 mins):Health News:Induction Brazing Equipment Series From DaWei Induction Heating Co., A Reliable Supplier Of Induction Heating Equipment 2Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 2Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 3Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:iFitDress.com: Black One-Shoulder Cocktail Dresses for 2015 2Health News:BellasDress.com’s Christmas Sale: Trendy Wedding Dresses With Big Discounts 2
... cardiac surgery capability can perform nonemergency angioplasty and stent ... surgery. That is the finding of the nation,s ... just as well having nonemergency angioplasty performed at smaller, ... Results of the study, called the Cardiovascular Patient Outcomes ...
... Mann HealthDay Reporter , MONDAY, Nov. 14 ... injection of a man-made protein might lower levels of ... AMG145 reduced low-density lipoprotein (LDL) cholesterol levels among ... a newly identified cholesterol regulator, PCSK9, which interferes with ...
... in the Princess Margaret Cancer Program have found a promising ... new way. The proof-of-concept research published today in ... discovered that the antibiotic tigecycline targets and destroys leukemia stem ... you think of all the cells in the body as ...
... HealthDay Reporter , MONDAY, Nov. 14 (HealthDay News) ... medications if they,re free, U.S. researchers find. Less than ... prescribed medications, which increases hospitalizations, deaths and costs to the ... eliminating the co-pay fee might entice more patients to take ...
... network led by a Mayo Clinic physician found that stem ... after a person has a heart attack did not improve ... the timing and method of stem cell delivery and provides ... The results were presented this morning at the 2011 Scientific ...
... sufferers, a day can feel like a year and a year ... approved by the U.S. Food and Drug Administration for this condition ... the FDA has taken note. With up to $4.5 million in ... the University of Rochester Medical Center will study different approaches to ...
Cached Medicine News:Health News:Patients fare just as well if their nonemergency angioplasty is performed at hospitals 2Health News:Patients fare just as well if their nonemergency angioplasty is performed at hospitals 3Health News:Shot Might One Day Help Lower Cholesterol 2Health News:Shot Might One Day Help Lower Cholesterol 3Health News:Canadian researchers find potential new leukemia treatment with old antibiotic drug 2Health News:More Heart Attack Patients Take Meds When They Are Free 2Health News:More Heart Attack Patients Take Meds When They Are Free 3Health News:Stem cell study helps clarify the best time for therapy to aid heart attack survivors 2Health News:Stem cell study helps clarify the best time for therapy to aid heart attack survivors 3Health News:FDA funds Rochester researchers to give chronic and acute pain clinical trials a makeover 2Health News:FDA funds Rochester researchers to give chronic and acute pain clinical trials a makeover 3
(Date:12/24/2014)... -- Commonwealth Cornerstone Group (CCG) today announced the completion of an ... help fund the expansion and consolidation of healthcare services provided ... . PHN is the largest federally qualified ... is the largest employer in Sharon,s ... Currently, PHN Sharon offers scattered services out of ...
(Date:12/24/2014)... 24, 2014 Kinex Pharmaceuticals announced today that ... Roswell Park Cancer Institute. KX2-361 (KX02), a ... has shown potent inhibitory activity against a broad panel ... resistant to Temozolomide (T98G), the most widely used chemotherapy ... brain tumor mouse model, KX2-361 consistently clears brain tumors ...
(Date:12/24/2014)... Trade Commission (ITC) issued its final decision in the case ... issued on December 23, the ITC ruled in favor of ... invalid. BMC President, James Xu called ... the ITC,s decision in this case. This victory for us ... beginning on the key patents in the case. ResMed chose ...
Breaking Medicine Technology:Commonwealth Cornerstone Group Announces $8 Million in Tax Credits to Expand and Consolidate Healthcare Services in Sharon 2Commonwealth Cornerstone Group Announces $8 Million in Tax Credits to Expand and Consolidate Healthcare Services in Sharon 3Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 2Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 3ITC Final Decision Goes Against ResMed (RMD) Monumental Win for 3B/BMC 2
... R1626 into phase IIb study, called POLI 1 ... of Roche,s new,investigational drugs for chronic hepatitis C ... given in combination with,PEGASYS(R) (peginterferon alfa-2a) and COPEGUS(TM) ... Association for the Study of the,Liver Disease (AASLD) ...
... MCLEAN, Va., Nov. 1 Science,Applications International Corporation ... awarded a contract extension by the National Institute ... and Infectious,Diseases (DMID), part of the National Institutes ... services. The seven-year cost-plus-fixed-fee contract has an ...
Cached Medicine Technology:Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks 2Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks 3Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks 4Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks 5Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks 6Roche's Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks 7SAIC Awarded Malaria Vaccine Production Support Contract Extension by the National Institute of Allergy and Infectious Diseases 2
... The TOPCON ALE-3600 and ... assure perfectly fit lenses ... and with the convenience ... These lens edgers are ...
Inquire...
... have two choices for finishing. The first choice ... wholesale lab, which meant longer delay to deliver ... order in house, but that meant a substantial ... inventory, more space and employee training. TOPscan Remote ...
... Ergonomic, computer-integrated, flexibility, combined with the ... contemporary styling, make the new Topcon ... highly competitive 21st Century practice environments: ... lane fits comfortably in an 8' ...
Medicine Products: